Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Horizon Pharma Ord (HZNP)

15.01 -0.1 (-0.66%)

05-21 16:00

Open:

15.11

Pre. Close:

15.11

High:

15.17

Low:

14.9

Volume:

2,141,252

Market Cap:

2477M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

15.179 - 15.256

15.256 - 15.316

Low:

14.719 - 14.8

14.8 - 14.863

Close:

14.881 - 15.018

15.018 - 15.123

Technical analysis  (as of: 2018-05-21 4:30:13 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 17.87     One year: 20.87

Support:

Support1: 13.60    Support2: 12.55

Resistance:

Resistance1: 15.30    Resistance2: 17.87

Pivot:

14.49

Moving Averages:

MA(5): 15.01     MA(20): 14.26

MA(100): 14.52     MA(250): 13.56

MACD:

MACD(12,26): 0.28     Signal(12,26,9): 0.15

%K %D:

%K(14,3): 92.79     %D(3): 92.86

RSI:

RSI(14): 59.98

52-Week:

High: 16.02  Low: 9.9  Change(%): 47.6

Average Vol(K):

3-Month: 195076  10-Days 242478

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
HZNP has closed below upper band by 22.9%. Bollinger Bands are 23.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-18T10:09:17-04:00
Tracking John Paulson's Paulson & Co. Portfolio - Q1 2018 Update

2018-05-09T13:29:12-04:00
Horizon Pharma plc 2018 Q1 - Results - Earnings Call Slides

2018-05-09T12:25:10-04:00
Horizon Pharma Plc (HZNP) Q1 2018 Results - Earnings Call Transcript

2018-05-09T08:07:08-04:00
Horizon Pharma Q1 top line up 1%; non-GAAP earnings down 86%; guidance raised; operating structure revamped

2018-05-09T07:02:49-04:00
Horizon Pharma misses by $0.04, misses on revenue

2018-05-08T17:30:28-04:00
Notable earnings before Wednesday's open

2018-05-02T10:47:42-04:00
Cirius Therapeutics completes enrollment in mid-stage study of lead candidate in NASH

2018-04-19T12:12:03-04:00
Institutional Top Ideas Series: Scopia Capital

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

165.04

Shares Float (M)

163.25

% Held by Insiders

1.10

% Held by Institutions

85.70

Shares Short (K)

9754

Shares Short Prior Month (K)

14730

Stock Financials

EPS

0.990

EPS Est. Current Year

1.070

EPS Est. Next Year

1.250

EPS Est. Next Quarter

0.230

Forward EPS

1.769

Book Value (p.s.)

2.730

PEG Ratio

0.75

Profit Margin

-45.06

Operating Margin

-9.38

Return on Assets (ttm)

-11.4

Return on Equity (ttm)

-46.2

Qtrly Rev. Growth

1.4

Gross Profit (p.s.)

1.851

Sales Per Share

EBITDA (p.s.)

-0.423

Qtrly Earnings Growth

Operating Cash Flow (M)

194.59

Levered Free Cash Flow (M)

364.98

atoplab.com

Valuation

P/E

15.16

P/E Growth Ratio

-0.01

P/BV

5.50

P/S

382882592.00

P/CF

12.73

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.